Allergan (AGN) Misses Q3 EPS Views; Offers Pipeline, FY16 Guidance Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. WDAY
2. JNJ
3. AAPL
4. META
5. AMAT
6. NRIX
7. SUNS
8. SPY
9. CRDO
10. OIG

Go back to Allergan (AGN) Misses Q3 EPS Views; Offers Pipeline, FY16 Guidance Updates

Allergan Reports Third Quarter 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion; Announces Accelerated Share Repurchase, Initiation of Cash Dividend

November 2, 2016 6:35 AM EDT

DUBLIN, Nov. 2, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today reported its third quarter 2016 continuing operations performance.

Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO

Third Quarter 2016 Continuing Operations

($ in millions, except per share amounts)

Q3 '16

Q3 '15

Q2 '16

Q3 '16 v Q3 '15

Q3 '16 v Q2 '16

Total net revenues*

$    ... More

Allergan Announces $10 Billion Accelerated Share Repurchase, Initiation of Cash Dividend in 2017

November 2, 2016 6:30 AM EDT

DUBLIN, Nov. 2, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that it has completed its initial $5 billion in share repurchases under its previously announced share repurchase program, and its Board of Directors has approved the expansion of the share repurchase program and the initiation of a regular quarterly cash dividend for shareholders as part of the Company's capital allocation strategy. This reflects the Company's conviction in its business strategy and strong future cash flow position, allowing for periodic return of cash to shareholders through dividends and a significant share buyback program while... More